Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?

Immunotherapy using checkpoint inhibitor targeting PD-1 and PD-L1 revolutionized the treatment of microsatellite instable metastatic colon cancer. Such treatment is now a standard of care for these patients. However, when used as monotherapy checkpoint inhibitors targeting PD-1 and PD-L1 are not eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghiringhelli, François, Fumet, Jean-David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691024/
https://www.ncbi.nlm.nih.gov/pubmed/31447840
http://dx.doi.org/10.3389/fimmu.2019.01816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691024/
https://www.ncbi.nlm.nih.gov/pubmed/31447840
http://dx.doi.org/10.3389/fimmu.2019.01816

Ejemplares similares